Literature DB >> 18778718

Telomeric chromatin: roles in aging, cancer and hereditary disease.

R A McCord1, D Broccoli.   

Abstract

Over the last several years there has been an explosion in our understanding of the organization of telomeric chromatin in mammals. As in other regions of the genome, chromatin composition at the telomere regulates structure, which defines function. Mammalian telomeres, similar to what has been demonstrated for telomeres of other eukaryotes, carry marks of heterochromatin and alteration in this underlying epigenetic code has effects on telomere replication and recombination. Experiments aimed at determining links between changes in telomeric chromatin and possible roles in aging and disease are beginning to emerge. The rapid refinement of our knowledge of the structure and alterations in telomeric chromatin over the last several years makes it likely that we are just seeing the tip of the iceberg.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778718     DOI: 10.1016/j.mrfmmm.2008.08.005

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

Review 1.  Dynamic energy budget approaches for modelling organismal ageing.

Authors:  Ingeborg M M van Leeuwen; Julio Vera; Olaf Wolkenhauer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-11-12       Impact factor: 6.237

Review 2.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 3.  The long-term impact of adverse caregiving environments on epigenetic modifications and telomeres.

Authors:  Jennifer Blaze; Arun Asok; Tania L Roth
Journal:  Front Behav Neurosci       Date:  2015-04-08       Impact factor: 3.558

4.  The Myb/SANT domain of the telomere-binding protein TRF2 alters chromatin structure.

Authors:  Asmaa M Baker; Qiang Fu; William Hayward; Stuart M Lindsay; Terace M Fletcher
Journal:  Nucleic Acids Res       Date:  2009-06-16       Impact factor: 16.971

Review 5.  Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases.

Authors:  Oscar Teijido; Ramón Cacabelos
Journal:  Int J Mol Sci       Date:  2018-10-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.